Remarkably, 57% of patients clinically diagnosed with non-NF2-related SWN but without germline LZTR1 or SMARCB1 lesions exhibit mosaic NF2-related SWN as determined by identical pathogenic NF2 variants detected in two independent schwannomas [32, 84]. Here, SMARCB1 is linked to schwannoma.